Want to know more about #MANIFESTuk?
To stimulate collaborations, we have openly shared our vision, workflow overview and long term plans in this latest perspective piece in Cancer Discovery.
Check it out.
@manifest-cirrp.bsky.social
@manifest-cirrp.bsky.social
UK-wide cancer immunotherapy response research platform | MANIFEST: Multiomic ANalysis of Immunotherapy Features Evidencing Success & Toxicity π https://www.manifest-io.org.uk
Want to know more about #MANIFESTuk?
To stimulate collaborations, we have openly shared our vision, workflow overview and long term plans in this latest perspective piece in Cancer Discovery.
Check it out.
@manifest-cirrp.bsky.social
π We finally had our first in-person #MANIFESTuk consortium meeting @crick.ac.uk today.
So delighted to welcome >100 colleagues from up & down the country π¬π§, including our industry partners, to discuss science & the vision + ambitions of MANIFEST.
Letβs keep going! π
@manifest-cirrp.bsky.social
Our keynote speaker Elana Fertig (@univofmaryland.bsky.social) presenting some fantastic work on βModelling the TME of clinical trials with virtual cellsβ π¦ π₯οΈ
12.05.2025 15:16 β π 1 π 0 π¬ 0 π 0Ajitha Rajan (@edinburgh-uni.bsky.social) joins us over the web to present on βMultimodal Data Integrationβ π¬
12.05.2025 14:23 β π 1 π 0 π¬ 0 π 1Up next, Santiago Zelenay (@cruk-mi.bsky.social) presents his work on setting up a βPatient Derived Tumour Fragment platformβ π§«
12.05.2025 13:42 β π 4 π 1 π¬ 0 π 1Anne-Laure Cattin (@crick.ac.uk) starts the third session presenting some amazing work on βDeconvoluting the in situ tumour immune microenvironmentβ π§«π¬
12.05.2025 13:24 β π 1 π 0 π¬ 0 π 1Up next Dominic Rothwell (@cruknbc.bsky.social) presents βcfDNA methylation profiling as a precision medicine biomarker in cancerβ π§¬π
12.05.2025 11:38 β π 1 π 0 π¬ 0 π 1James Jones (@cruk-ci.bsky.social) presents amazing work on βCytokine profiling in kidney cancer translational studiesβ π₯
12.05.2025 11:29 β π 2 π 1 π¬ 0 π 0@maxemmerichderm.bsky.social (@crick.ac.uk) kicks off the second session presenting βComprehensive blood profiling to derive immune signatures predictive of checkpoint inhibitor response and toxicityβ. π©Έβ’οΈ
12.05.2025 11:14 β π 1 π 1 π¬ 0 π 0π― Delighted that the May 2025 issue of Cancer Discovery @theaacr.bsky.social features #MANIFESTuk!
Check out this βIn Focusβ piece summarising our vision and ambitions for #CancerImmunotherapy π
aacrjournals.org/cancerdiscov...
@manifest-cirrp.bsky.social
π‘Inspiring to be in amongst esteemed colleagues at BSI Cancer Immunotherapies Summit today at The Royal Society.
Happy to share our vision & ambitions for #MANIFESTuk + how we can work collaboratively to tackle some of the biggest questions in immuno-oncology.
@manifest-cirrp.bsky.social
π¨Opportunity to join the MANIFEST team βΌοΈ
Weβre looking for:
π» A Talented ML Engineer
To:
β‘οΈ Join a team of computational biologists
πDeliver on integrated immune-oncology biomarker signatures
π@crick.ac.uk @TurajlicLab
π§βπ»manifest-io.org.uk
Link π:
crick.wd3.myworkdayjobs.com/External/job/Lβ¦
Fantastic to see @manifest-cirrp.bsky.social represented at Manchester Immuno-Oncology Network (MION) Spring Event.
π₯ 𧬠Criticial work will be led by colleagues & co-investigators:
π @cruk-mi.bsky.social
π @mcrcnews.bsky.social
π @cruknbc.bsky.social
π The Christie
π First set of results since launch of #MANIFESTuk - our wide-utility multiomic platform for cancer immunotherapy.
Congratulations to our very own @maxemmerichderm.bsky.social for the oral presentation at the inaugural #AACRIO25 Congress - HD-immunoprofiling from blood π©Έ.
Check it out π
π¨First output from the MANIFEST platformβΌοΈ
π©ΈPBMC derived immune signatures can predict ICI response & tox!
π§βπ» Hugely collaborative effort led by @maxemmerichderm.bsky.social & Turajlic Lab in conjunction with #IMUBiosciences
πWatch this space for multimodal composite biomarkers
Opportunity to reflect on the challenges of biomarker discovery in RCCβΌοΈ#GU25
Need for:
π Sample & Data Harmonisation
π΄ Overcome pervasive heterogeneity
π©ΈIncorporation of dynamic measures
π§ Collaborative efforts
β‘οΈ Generation of multimodal biomarker signatures
π§βπ»: manifest-io.org.uk
Fantastic to see integrated translational analyses presented on the podium at #GU25 π§¬π¬
Elegantly presented by Prof Albiges
π¨ Watch this space for integrated molecular & spatial profiling in advanced ccRCC for patients undergoing ICI therapies
ππΎ
π§βπ»manifest-io.org.uk
π¦ Spotlight on ctDNA as Biomarker in Bladder Ca.
π΄ Emerging role as a surrogate for path response & survival βΌοΈ
Need for:
π Prospective efforts w/ embedded sampling timepoints
π§βπ» Combinatorial Biomarkers
π Data Harmonisation
#GU25
π¨Follow @manifest-cirrp.bsky.social
𧬠Aiming to generate multimodal biomarker signatures incl & beyond ctDNA & PD-L1 expression in Bladder Ca
π§πΎβπ» manifest-io.org.uk
#GU25
Excited to contribute to this spaceβΌοΈ
Critical to this will be a strong theme of cross-collaboration π₯𧬠& knowledge-sharing π§
Great to see members of the consortium together at #Immuno25
π More exciting opportunities to join the @manifest-cirrp.bsky.social consortium at @crick.ac.uk!
We are looking for:
π» ML engineer
π¬ Senior Laboratory Research Scientist (Spatial Profiling)
π§βπ¬ Senior Laboratory Research Scientist (Flow Cytometry)
Apply now π www.crick.ac.uk/careers-and-...
π
Deadline: 8th January 2025
π Apply here: crick.ac.uk/careers-and-...
π» Find out more: manifest-io.org.uk/about
π’ New job opportunities open in computational modelling, genomics and imaging for Postdoctoral and Senior Scientists based @crick.ac.uk!
π§βπ¬ Become part of MANIFEST, a UK-wide consortium of 14 academic institutions, 6 NHS trusts and several industry partners all tackling challenges in #immunotherapy
π¦ MANIFEST is excited to join the @bsky.app community!
π§βπ¬ We are looking forward to connecting with academics, clinicians, patients and industry with interests in #immunotherapy, #immunooncology, #clinicaltrials, #translationalresearch and more
π€ Together, we can advance cancer care for patients